The association of bile acid and thyroid hormone levels in intrahepatic cholestasis of pregnancy

Intrahepatic cholestasis of pregnancy (ICP) leads to adverse perinatal outcomes and these outcomes are affected by high total bile acid (TBA) levels. Studies have shown that thyroid hormones regulate bile acid metabolism. However, few studies have evaluated the role of thyroid hormones in ICP. Objec...

Descripción completa

Detalles Bibliográficos
Autores: Golbasi, Ceren, Golbasi, Hakan, Bayraktar, Burak, Omeroglu, Ibrahim, Ekin, Atalay
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2022
País:Perú
Institución:Sociedad Peruana de Obstetricia y Ginecología
Repositorio:Revista Peruana de Ginecología y Obstetricia
Idioma:español
inglés
OAI Identifier:oai:ginecologiayobstetricia.pe:article/2428
Acceso en línea:https://ginecologiayobstetricia.pe/index.php/RPGO/article/view/2428
Access Level:acceso abierto
Palabra clave:Cholestasis
intrahepatic
Pregnancy
complications
Thyroid hormones
Thyroid-stimulating hormone
Bile acid
Colestasis intrahepática
Embarazo
complicaciones
Hormonas tiroideas
Hormona estimulante de la tiroides
Ácido biliar
Descripción
Sumario:Intrahepatic cholestasis of pregnancy (ICP) leads to adverse perinatal outcomes and these outcomes are affected by high total bile acid (TBA) levels. Studies have shown that thyroid hormones regulate bile acid metabolism. However, few studies have evaluated the role of thyroid hormones in ICP. Objective: To evaluate thyroid function along with TBA levels in ICP. Methods: In this retrospective study, 252 pregnant women, including 126 ICP and 126 controls, were evaluated. Third trimester TBA, thyroid-stimulating hormone (TSH), and free thyroxine (fT4) levels of all pregnant women were assessed. Correlation between TBA and fT4, TSH levels were examined. In addition, the perinatal outcomes of both groups were determined. Results: fT4 levels were significantly higher in ICP. There was also a positive correlation between fT4 and TBA levels. TSH levels were similar in both groups and there was no significant correlation with TBA levels. There was no significant difference between the two groups in thyroid diseases in the third trimester. Conclusions: Higher fT4 level was associated with higher TBA level and fT4 level was associated with higher ICP risk and ICP severity, but TSH level was not associated with higher TBA and higher ICP risk.